Compound of the avermectin family or of the milbemycin family for the treatment and/or prevention of atopic dermatitis

Abstract

The present invention relates to a pharmaceutical composition comprising a compound of the avermectin family, preferably ivermectin, or a compound of the milbemycin family in a pharmaceutically acceptable carrier, for use in the treatment and / or prevention of atopic dermatitis.

Description

technical field [0001] The invention relates to a pharmaceutical composition suitable for treating and / or preventing atopic dermatitis. Background technique [0002] Dermatitis is derived from the Greek words "derma" and "itis", "derma" meaning skin and "itis" meaning inflammation. Dermatitis thus corresponds to inflammation of the skin, classified into several specific and different types of dermatitis according to its location, etiology and symptoms. Non-exhaustive examples of dermatitis are contact dermatitis, dermatitis herpetiformis, acrodermatitis, exfoliative dermatitis, perioral dermatitis, seborrheic dermatitis, and atopic dermatitis. [0003] Atopic dermatitis is an epidermal disorder that affects a large number of genetically predisposed individuals, including infants, children and pregnant women. Typically, atopic dermatitis begins in infancy and early childhood, especially around the age of 2 months. About 50% of atopic dermatitis cases begin before the age o...

AI Technical Summary

Problems solved by technology

However, conventional management of atopic dermatitis with steroids and antihistamines provides only temporary relief of symptoms

Images